The American Heart Association (AHA) released a statement regarding the use of complementary and alternative treatments that are used in the United States for the treatment of heart failure symptoms.
The American College of Physicians updated its set of guidelines on the pharmacologic treatment of primary osteoporosis based on current evidence and research.
The FDA has granted accelerated approval to linvoseltamab-gcpt, a BCMA-directed bispecific T-cell engager, offering a new option for patients with heavily pretreated relapsed or refractory multiple myeloma....